ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
Case Western Reserve study finds gut bacteria sugars trigger immune attacks linked to ALS and frontotemporal dementia in C9orf72-deficient individuals.
Read More
Mississippi State Health Officer Dr. Daniel P. Edney declined the nomination to become director of the CDC, officials confirmed Thursday.
Read More
Studies show plant compounds like menthol and capsaicin reduce chronic inflammation in diabetes and cancer by targeting cellular pathways.
Read More
Johns Hopkins researchers identify CSE enzyme and hydrogen sulfide as potential targets to prevent Tau protein-related Alzheimer’s progression.
Read More
As Hungary votes April 12, Russian GRU operatives, bot networks, and AI-generated deepfakes flood Facebook while Meta looks the other way. A comprehensive investigation into the Kremlin’s election interference machine and Zuckerberg’s complicity.
Read More
Studies show direct oral challenge safely removes penicillin allergies in hospitals, increasing penicillin use 13-fold within 90 days.
Read More
A study finds stopping Ozempic or Wegovy for six months or more reverses cardiovascular benefits in type 2 diabetes patients.
Read More
A UK Biobank study found that highest physical activity levels reduce risk of 13 cancer types by 26%, based on accelerometer data.
Read More
The FDA approved Novo Nordisk’s 25 mg oral Wegovy semaglutide tablet for adult weight management, launching in January 2026.
Read More
Researchers developed a DNA-based drug that activates only in cancer cells expressing two tumor markers, improving targeted treatment precision.
Read More
